157 related articles for article (PubMed ID: 38446899)
21. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
22. Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial.
Zhang ZJ; Man SC; Yam LL; Yiu CY; Leung RC; Qin ZS; Chan KS; Lee VHF; Kwong A; Yeung WF; So WKW; Ho LM; Dong YY
Brain Behav Immun; 2020 Aug; 88():88-96. PubMed ID: 32305573
[TBL] [Abstract][Full Text] [Related]
23. Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain.
Chunchai T; Pintana H; Arinno A; Ongnok B; Pantiya P; Khuanjing T; Prathumsap N; Maneechote C; Chattipakorn N; Chattipakorn SC
Neurotoxicology; 2023 Jan; 94():158-171. PubMed ID: 36463981
[TBL] [Abstract][Full Text] [Related]
24. Senolytic treatment alleviates doxorubicin-induced chemobrain.
Budamagunta V; Kumar A; Rani A; Manohar Sindhu S; Yang Y; Zhou D; Foster TC
Aging Cell; 2024 Feb; 23(2):e14037. PubMed ID: 38225896
[TBL] [Abstract][Full Text] [Related]
25. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Tong Y; Wang K; Sheng S; Cui J
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
[TBL] [Abstract][Full Text] [Related]
26. Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice.
Chiang ACA; Seua AV; Singhmar P; Arroyo LD; Mahalingam R; Hu J; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2020 Nov; 8(1):193. PubMed ID: 33183353
[TBL] [Abstract][Full Text] [Related]
27. Neuropathological Effects of Chemotherapeutic Drugs.
Umfress A; Speed HE; Tan C; Ramezani S; Birnbaum S; Brekken RA; Sun X; Plattner F; Powell CM; Bibb JA
ACS Chem Neurosci; 2021 Aug; 12(16):3038-3048. PubMed ID: 34370453
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy-Induced Cognitive Impairment.
Kinsley K; Pritchett W
Clin J Oncol Nurs; 2023 Mar; 27(2):205-208. PubMed ID: 37677835
[TBL] [Abstract][Full Text] [Related]
29. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
30. Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment.
Milutinovic B; Mahalingam R; Mendt M; Arroyo L; Seua A; Dharmaraj S; Shpall E; Heijnen CJ
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511623
[TBL] [Abstract][Full Text] [Related]
31. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
32. Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks.
Wahdan SA; El-Derany MO; Abdel-Maged AE; Azab SS
Neurochem Int; 2020 Sep; 138():104777. PubMed ID: 32479984
[TBL] [Abstract][Full Text] [Related]
33. Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways.
Ongnok B; Prathumsap N; Chunchai T; Pantiya P; Arunsak B; Chattipakorn N; Chattipakorn SC
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38568417
[TBL] [Abstract][Full Text] [Related]
34. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
35. Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice.
Zhou W; Kavelaars A; Heijnen CJ
PLoS One; 2016; 11(3):e0151890. PubMed ID: 27018597
[TBL] [Abstract][Full Text] [Related]
36. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.
Gibson EM; Nagaraja S; Ocampo A; Tam LT; Wood LS; Pallegar PN; Greene JJ; Geraghty AC; Goldstein AK; Ni L; Woo PJ; Barres BA; Liddelow S; Vogel H; Monje M
Cell; 2019 Jan; 176(1-2):43-55.e13. PubMed ID: 30528430
[TBL] [Abstract][Full Text] [Related]
38. C-phycocyanin Mitigates Cognitive Impairment in Doxorubicin-Induced Chemobrain: Impact on Neuroinflammation, Oxidative Stress, and Brain Mitochondrial and Synaptic Alterations.
Wang C; Zhao Y; Wang L; Pan S; Liu Y; Li S; Wang D
Neurochem Res; 2021 Feb; 46(2):149-158. PubMed ID: 33237471
[TBL] [Abstract][Full Text] [Related]
39. "Chemobrain" in childhood cancer survivors-the impact on social, academic, and daily living skills: a qualitative systematic review.
Semendric I; Pollock D; Haller OJ; George RP; Collins-Praino LE; Whittaker AL
Support Care Cancer; 2023 Aug; 31(9):532. PubMed ID: 37606711
[TBL] [Abstract][Full Text] [Related]
40. Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats.
Shaker FH; El-Derany MO; Wahdan SA; El-Demerdash E; El-Mesallamy HO
Life Sci; 2021 Mar; 269():119078. PubMed ID: 33460662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
